Consumers Health Forum worried on biosimilars

white pills and tablets: GMiA
The Consumers Health Forum has expressed its concerns about the issue of substitution of biological medicines with biosimilars, at a meeting called by the Pharmaceutical Benefits Advisory Committee. CEO of the Forum, Leanne Wells, says that at the meeting there was “a consistency in the concern and opposition from clinical and consumer groups concerning the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Clinical tips: hepatitis C explained
Next Deakin Uni professor busts the biggest diabetes myths